Veterinary Pharmaceuticals Market 2027 By Product, End User, Route of Administration, Type of Animals, Vaccines, Antibiotics | The Insight Partners

Veterinary Pharmaceuticals Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Vaccines, Antibiotics, Parasiticides, Others); End User (Hospitals, Clinics, Pharmacies And Drug Stores); Route of Administration (Oral, Others); Type of Animals (Livestock, Companion Animals); Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others); Antibiotics (Tetracyclines, Penicillins, Sulphonamides, Macrolides, Aminoglycosides, Others)

Report Code: TIPRE00011314 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Veterinary pharmaceuticals include drugs, medicines, and other substances in use to treat or prevent animal diseases for health, growth promotion, and productivity. These drugs can be broadly divided into categories according to the different pathogens or targeted infections.

MARKET DYNAMICS

The veterinary pharmaceuticals market is increasing penetration of pet insurance will increase the number of visits at veterinary clinics supporting the use of veterinary pharmaceuticals. Moreover, increased pet spending and increased disease prevalence is boosting to the growth of the market for veterinary pharmaceuticals.

MARKET SCOPE

The "Veterinary Pharmaceuticals Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of veterinary pharmaceuticals market with detailed market segmentation by product, end user, route of administration, type of animals, vaccines and antibiotics. The veterinary pharmaceuticals market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in veterinary pharmaceuticals market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The veterinary pharmaceuticals market is segmented on the basis of product, end user, route of administration, type of animals, vaccines and antibiotics. Based on product, the market is segmented as vaccines, antibiotics, parasiticides and others. On the basis of end users, the market is categorized as hospitals, clinics, pharmacies and drug stores. On the basis of route of administration, the market is categorized as oral and others. On the basis of type of animals, the market is categorized as livestock and companion animals. On the basis of vaccines, the market is categorized as inactivated vaccines, attenuated vaccines, recombinant vaccines and others. On the basis of antibiotics, tetracyclines, penicillins, sulphonamides, macrolides, aminoglycosides and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the veterinary pharmaceuticals market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The veterinary pharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting veterinary pharmaceuticals market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the veterinary pharmaceuticals market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the veterinary pharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from veterinary pharmaceuticals market are anticipated to have lucrative growth opportunities in the future with the rising demand for veterinary pharmaceuticals in the global market. Below mentioned is the list of few companies engaged in the veterinary pharmaceuticals market.

The report also includes the profiles of key players in veterinary pharmaceuticals market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Aratana Therapeutics, Inc.
  •   Bayer AG
  •   Boehringer Ingelheim International GmbH
  •   Ceva Sante Animale
  •   Dechra Pharmaceuticals PLC
  •   Elanco Animal Health Inc.
  •   Eli Lilly and Company
  •   Merck & Co., Inc.
  •   Virbac
  •   Zoetis Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Veterinary Pharmaceuticals Market - By Product
1.3.2 Veterinary Pharmaceuticals Market - By End User
1.3.3 Veterinary Pharmaceuticals Market - By Route of Administration
1.3.4 Veterinary Pharmaceuticals Market - By Type of Animals
1.3.5 Veterinary Pharmaceuticals Market - By Vaccines
1.3.6 Veterinary Pharmaceuticals Market - By Antibiotics
1.3.7 Veterinary Pharmaceuticals Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VETERINARY PHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VETERINARY PHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VETERINARY PHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. VETERINARY PHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. VETERINARY PHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VACCINES
7.3.1. Overview
7.3.2. Vaccines Market Forecast and Analysis
7.4. ANTIBIOTICS
7.4.1. Overview
7.4.2. Antibiotics Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. PHARMACIES AND DRUG STORES
8.5.1. Overview
8.5.2. Pharmacies And Drug Stores Market Forecast and Analysis
9. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. OTHERS
9.4.1. Overview
9.4.2. Others Market Forecast and Analysis
10. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF ANIMALS
10.1. OVERVIEW
10.2. TYPE OF ANIMALS MARKET FORECASTS AND ANALYSIS
10.3. LIVESTOCK
10.3.1. Overview
10.3.2. Livestock Market Forecast and Analysis
10.4. COMPANION ANIMALS
10.4.1. Overview
10.4.2. Companion Animals Market Forecast and Analysis
11. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - VACCINES
11.1. OVERVIEW
11.2. VACCINES MARKET FORECASTS AND ANALYSIS
11.3. INACTIVATED VACCINES
11.3.1. Overview
11.3.2. Inactivated Vaccines Market Forecast and Analysis
11.4. ATTENUATED VACCINES
11.4.1. Overview
11.4.2. Attenuated Vaccines Market Forecast and Analysis
11.5. RECOMBINANT VACCINES
11.5.1. Overview
11.5.2. Recombinant Vaccines Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis
12. VETERINARY PHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2027 - ANTIBIOTICS
12.1. OVERVIEW
12.2. ANTIBIOTICS MARKET FORECASTS AND ANALYSIS
12.3. TETRACYCLINES
12.3.1. Overview
12.3.2. Tetracyclines Market Forecast and Analysis
12.4. PENICILLINS
12.4.1. Overview
12.4.2. Penicillins Market Forecast and Analysis
12.5. SULPHONAMIDES
12.5.1. Overview
12.5.2. Sulphonamides Market Forecast and Analysis
12.6. MACROLIDES
12.6.1. Overview
12.6.2. Macrolides Market Forecast and Analysis
12.7. AMINOGLYCOSIDES
12.7.1. Overview
12.7.2. Aminoglycosides Market Forecast and Analysis
12.8. OTHERS
12.8.1. Overview
12.8.2. Others Market Forecast and Analysis
13. VETERINARY PHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Veterinary Pharmaceuticals Market Overview
13.1.2 North America Veterinary Pharmaceuticals Market Forecasts and Analysis
13.1.3 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.1.4 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.1.5 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.1.6 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.1.7 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.1.8 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.1.9 North America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.1.9.1 United States Veterinary Pharmaceuticals Market
13.1.9.1.1 United States Veterinary Pharmaceuticals Market by Product
13.1.9.1.2 United States Veterinary Pharmaceuticals Market by End User
13.1.9.1.3 United States Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.1.4 United States Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.1.5 United States Veterinary Pharmaceuticals Market by Vaccines
13.1.9.1.6 United States Veterinary Pharmaceuticals Market by Antibiotics
13.1.9.2 Canada Veterinary Pharmaceuticals Market
13.1.9.2.1 Canada Veterinary Pharmaceuticals Market by Product
13.1.9.2.2 Canada Veterinary Pharmaceuticals Market by End User
13.1.9.2.3 Canada Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.2.4 Canada Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.2.5 Canada Veterinary Pharmaceuticals Market by Vaccines
13.1.9.2.6 Canada Veterinary Pharmaceuticals Market by Antibiotics
13.1.9.3 Mexico Veterinary Pharmaceuticals Market
13.1.9.3.1 Mexico Veterinary Pharmaceuticals Market by Product
13.1.9.3.2 Mexico Veterinary Pharmaceuticals Market by End User
13.1.9.3.3 Mexico Veterinary Pharmaceuticals Market by Route of Administration
13.1.9.3.4 Mexico Veterinary Pharmaceuticals Market by Type of Animals
13.1.9.3.5 Mexico Veterinary Pharmaceuticals Market by Vaccines
13.1.9.3.6 Mexico Veterinary Pharmaceuticals Market by Antibiotics
13.2. EUROPE
13.2.1 Europe Veterinary Pharmaceuticals Market Overview
13.2.2 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis
13.2.3 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.2.4 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.2.5 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.2.6 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.2.7 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.2.8 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.2.9 Europe Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Veterinary Pharmaceuticals Market
13.2.9.1.1 Germany Veterinary Pharmaceuticals Market by Product
13.2.9.1.2 Germany Veterinary Pharmaceuticals Market by End User
13.2.9.1.3 Germany Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.1.4 Germany Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.1.5 Germany Veterinary Pharmaceuticals Market by Vaccines
13.2.9.1.6 Germany Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.2 France Veterinary Pharmaceuticals Market
13.2.9.2.1 France Veterinary Pharmaceuticals Market by Product
13.2.9.2.2 France Veterinary Pharmaceuticals Market by End User
13.2.9.2.3 France Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.2.4 France Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.2.5 France Veterinary Pharmaceuticals Market by Vaccines
13.2.9.2.6 France Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.3 Italy Veterinary Pharmaceuticals Market
13.2.9.3.1 Italy Veterinary Pharmaceuticals Market by Product
13.2.9.3.2 Italy Veterinary Pharmaceuticals Market by End User
13.2.9.3.3 Italy Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.3.4 Italy Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.3.5 Italy Veterinary Pharmaceuticals Market by Vaccines
13.2.9.3.6 Italy Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.4 Spain Veterinary Pharmaceuticals Market
13.2.9.4.1 Spain Veterinary Pharmaceuticals Market by Product
13.2.9.4.2 Spain Veterinary Pharmaceuticals Market by End User
13.2.9.4.3 Spain Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.4.4 Spain Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.4.5 Spain Veterinary Pharmaceuticals Market by Vaccines
13.2.9.4.6 Spain Veterinary Pharmaceuticals Market by Antibiotics
13.2.9.5 United Kingdom Veterinary Pharmaceuticals Market
13.2.9.5.1 United Kingdom Veterinary Pharmaceuticals Market by Product
13.2.9.5.2 United Kingdom Veterinary Pharmaceuticals Market by End User
13.2.9.5.3 United Kingdom Veterinary Pharmaceuticals Market by Route of Administration
13.2.9.5.4 United Kingdom Veterinary Pharmaceuticals Market by Type of Animals
13.2.9.5.5 United Kingdom Veterinary Pharmaceuticals Market by Vaccines
13.2.9.5.6 United Kingdom Veterinary Pharmaceuticals Market by Antibiotics
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Veterinary Pharmaceuticals Market Overview
13.3.2 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis
13.3.3 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.3.4 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.3.5 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.3.6 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.3.7 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.3.8 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.3.9 Asia-Pacific Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Veterinary Pharmaceuticals Market
13.3.9.1.1 Australia Veterinary Pharmaceuticals Market by Product
13.3.9.1.2 Australia Veterinary Pharmaceuticals Market by End User
13.3.9.1.3 Australia Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.1.4 Australia Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.1.5 Australia Veterinary Pharmaceuticals Market by Vaccines
13.3.9.1.6 Australia Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.2 China Veterinary Pharmaceuticals Market
13.3.9.2.1 China Veterinary Pharmaceuticals Market by Product
13.3.9.2.2 China Veterinary Pharmaceuticals Market by End User
13.3.9.2.3 China Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.2.4 China Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.2.5 China Veterinary Pharmaceuticals Market by Vaccines
13.3.9.2.6 China Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.3 India Veterinary Pharmaceuticals Market
13.3.9.3.1 India Veterinary Pharmaceuticals Market by Product
13.3.9.3.2 India Veterinary Pharmaceuticals Market by End User
13.3.9.3.3 India Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.3.4 India Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.3.5 India Veterinary Pharmaceuticals Market by Vaccines
13.3.9.3.6 India Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.4 Japan Veterinary Pharmaceuticals Market
13.3.9.4.1 Japan Veterinary Pharmaceuticals Market by Product
13.3.9.4.2 Japan Veterinary Pharmaceuticals Market by End User
13.3.9.4.3 Japan Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.4.4 Japan Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.4.5 Japan Veterinary Pharmaceuticals Market by Vaccines
13.3.9.4.6 Japan Veterinary Pharmaceuticals Market by Antibiotics
13.3.9.5 South Korea Veterinary Pharmaceuticals Market
13.3.9.5.1 South Korea Veterinary Pharmaceuticals Market by Product
13.3.9.5.2 South Korea Veterinary Pharmaceuticals Market by End User
13.3.9.5.3 South Korea Veterinary Pharmaceuticals Market by Route of Administration
13.3.9.5.4 South Korea Veterinary Pharmaceuticals Market by Type of Animals
13.3.9.5.5 South Korea Veterinary Pharmaceuticals Market by Vaccines
13.3.9.5.6 South Korea Veterinary Pharmaceuticals Market by Antibiotics
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Veterinary Pharmaceuticals Market Overview
13.4.2 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis
13.4.3 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.4.4 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.4.5 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.4.6 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.4.7 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.4.8 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.4.9 Middle East and Africa Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Veterinary Pharmaceuticals Market
13.4.9.1.1 South Africa Veterinary Pharmaceuticals Market by Product
13.4.9.1.2 South Africa Veterinary Pharmaceuticals Market by End User
13.4.9.1.3 South Africa Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.1.4 South Africa Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.1.5 South Africa Veterinary Pharmaceuticals Market by Vaccines
13.4.9.1.6 South Africa Veterinary Pharmaceuticals Market by Antibiotics
13.4.9.2 Saudi Arabia Veterinary Pharmaceuticals Market
13.4.9.2.1 Saudi Arabia Veterinary Pharmaceuticals Market by Product
13.4.9.2.2 Saudi Arabia Veterinary Pharmaceuticals Market by End User
13.4.9.2.3 Saudi Arabia Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.2.4 Saudi Arabia Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.2.5 Saudi Arabia Veterinary Pharmaceuticals Market by Vaccines
13.4.9.2.6 Saudi Arabia Veterinary Pharmaceuticals Market by Antibiotics
13.4.9.3 U.A.E Veterinary Pharmaceuticals Market
13.4.9.3.1 U.A.E Veterinary Pharmaceuticals Market by Product
13.4.9.3.2 U.A.E Veterinary Pharmaceuticals Market by End User
13.4.9.3.3 U.A.E Veterinary Pharmaceuticals Market by Route of Administration
13.4.9.3.4 U.A.E Veterinary Pharmaceuticals Market by Type of Animals
13.4.9.3.5 U.A.E Veterinary Pharmaceuticals Market by Vaccines
13.4.9.3.6 U.A.E Veterinary Pharmaceuticals Market by Antibiotics
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Veterinary Pharmaceuticals Market Overview
13.5.2 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis
13.5.3 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Product
13.5.4 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By End User
13.5.5 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Route of Administration
13.5.6 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Type of Animals
13.5.7 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Vaccines
13.5.8 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Antibiotics
13.5.9 South and Central America Veterinary Pharmaceuticals Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Veterinary Pharmaceuticals Market
13.5.9.1.1 Brazil Veterinary Pharmaceuticals Market by Product
13.5.9.1.2 Brazil Veterinary Pharmaceuticals Market by End User
13.5.9.1.3 Brazil Veterinary Pharmaceuticals Market by Route of Administration
13.5.9.1.4 Brazil Veterinary Pharmaceuticals Market by Type of Animals
13.5.9.1.5 Brazil Veterinary Pharmaceuticals Market by Vaccines
13.5.9.1.6 Brazil Veterinary Pharmaceuticals Market by Antibiotics
13.5.9.2 Argentina Veterinary Pharmaceuticals Market
13.5.9.2.1 Argentina Veterinary Pharmaceuticals Market by Product
13.5.9.2.2 Argentina Veterinary Pharmaceuticals Market by End User
13.5.9.2.3 Argentina Veterinary Pharmaceuticals Market by Route of Administration
13.5.9.2.4 Argentina Veterinary Pharmaceuticals Market by Type of Animals
13.5.9.2.5 Argentina Veterinary Pharmaceuticals Market by Vaccines
13.5.9.2.6 Argentina Veterinary Pharmaceuticals Market by Antibiotics
14. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VETERINARY PHARMACEUTICALS MARKET
14.1 North America
14.2 Europe
14.3 Asia-Pacific
14.4 Rest of the World
15. INDUSTRY LANDSCAPE
15.1. MERGERS AND ACQUISITIONS
15.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
15.3. NEW PRODUCT LAUNCHES
15.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
16. VETERINARY PHARMACEUTICALS MARKET, KEY COMPANY PROFILES
16.1. ARATANA THERAPEUTICS, INC.
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Products and Services
16.1.4. Financial Overview
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.2. BAYER AG
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Products and Services
16.2.4. Financial Overview
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.3. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Products and Services
16.3.4. Financial Overview
16.3.5. SWOT Analysis
16.3.6. Key Developments
16.4. CEVA SANTE ANIMALE
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Products and Services
16.4.4. Financial Overview
16.4.5. SWOT Analysis
The List of Companies

1. Aratana Therapeutics, Inc.
2. Bayer AG
3. Boehringer Ingelheim International GmbH
4. Ceva Sante Animale
5. Dechra Pharmaceuticals PLC
6. Elanco Animal Health Inc.
7. Eli Lilly and Company
8. Merck & Co., Inc.
9. Virbac
10. Zoetis Inc.
TIPRE00011314
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking